Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into various mesenchymal tissues, including bone, cartilage, muscle, and fat. Recent research suggests that MSCs are naturally found as pericytes, which are released at sites of injury and secrete bioactive factors that promote tissue repair, angiogenesis, and immunomodulation. These factors inhibit apoptosis, reduce scarring, and stimulate the proliferation of tissue progenitor cells. MSCs also suppress immune responses, allowing their use in allogeneic therapies. This has led to a new era of clinical trials using MSCs for conditions such as graft-versus-host disease (GvHD), where they have shown significant therapeutic effects. MSCs can also promote the regeneration of bone and cartilage in animal models, and their ability to secrete bioactive molecules suggests that their therapeutic effects are primarily trophic rather than through differentiation into specific cell types. MSCs are found in close association with blood vessels, and their function as pericytes is crucial for maintaining tissue homeostasis. The number of MSCs in bone marrow decreases with age, which may relate to the slower healing rates observed in older individuals. MSCs have shown promise in treating various conditions, including osteoarthritis, stroke, and myocardial infarction, through their secreted growth factors and cytokines. Their ability to modulate immune responses and promote tissue repair makes them valuable for cell-based therapies. Further research is needed to fully understand their mechanisms and optimize their therapeutic applications.Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into various mesenchymal tissues, including bone, cartilage, muscle, and fat. Recent research suggests that MSCs are naturally found as pericytes, which are released at sites of injury and secrete bioactive factors that promote tissue repair, angiogenesis, and immunomodulation. These factors inhibit apoptosis, reduce scarring, and stimulate the proliferation of tissue progenitor cells. MSCs also suppress immune responses, allowing their use in allogeneic therapies. This has led to a new era of clinical trials using MSCs for conditions such as graft-versus-host disease (GvHD), where they have shown significant therapeutic effects. MSCs can also promote the regeneration of bone and cartilage in animal models, and their ability to secrete bioactive molecules suggests that their therapeutic effects are primarily trophic rather than through differentiation into specific cell types. MSCs are found in close association with blood vessels, and their function as pericytes is crucial for maintaining tissue homeostasis. The number of MSCs in bone marrow decreases with age, which may relate to the slower healing rates observed in older individuals. MSCs have shown promise in treating various conditions, including osteoarthritis, stroke, and myocardial infarction, through their secreted growth factors and cytokines. Their ability to modulate immune responses and promote tissue repair makes them valuable for cell-based therapies. Further research is needed to fully understand their mechanisms and optimize their therapeutic applications.